Table 5.
Comparison of the Sensitivity and Specificity of the Framingham and 10‐year ASCVD Risk Scoring Systems for the Alignment of Statin Therapy in Subjects According to CAC Score Progression
Framingham Risk Scoring | 2013 ASCVD Risk Scoring | P Valuea | |||||||
---|---|---|---|---|---|---|---|---|---|
Cutoff | Sensitivity | Specificity | AUC (95% CI) | Cutoff | Sensitivity | Specificity | AUC (95% CI) | ||
Progression | 5 | 76.2 | 48.6 | 0.66 (0.63–0.68) | 4.19 | 79.5 | 49.3 | 0.67 (0.64–0.70) | 0.056 |
ASCVD indicates atherosclerotic cardiovascular disease; AUC, area under the curve.
P value between Framingham and 10‐year ASCVD risk scoring system. P value is calculated by comparison of AUCs using the method of DeLong et al.10